Common controversies in the management of gallbladder cancer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Gallbladder cancer is a rare and lethal malignancy. Most patients are best served at high-volume centers of excellence, where they are likely to receive evidence-based care derived from a multidisciplinary approach. Surgical resection is recommended for early-stage disease, whereas if the disease is unresectable, the treatment options include biliary drainage, gemcitabine-based combination chemotherapy, fluoropyrimidine chemoradiation, clinical trial enrollment, or best supportive care. While treatment by T-stage is straightforward in many cases, the debate regarding simple versus radical cholecystectomy is still active for patients with T1b disease. Other controversies exist over the necessity of resecting the bile duct and port sites, the extent of lymph node dissection and hepatic resections, and the value of resection for patients with jaundice.

Original languageEnglish (US)
Pages (from-to)833-835
Number of pages3
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume12
Issue number5 SUPPL.
DOIs
StatePublished - May 1 2014

Fingerprint

Gallbladder Neoplasms
gemcitabine
Cholecystectomy
Jaundice
Bile Ducts
Combination Drug Therapy
Lymph Node Excision
Drainage
Clinical Trials
Liver
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

Common controversies in the management of gallbladder cancer. / Are, Chandrakanth.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 12, No. 5 SUPPL., 01.05.2014, p. 833-835.

Research output: Contribution to journalArticle

@article{009f190cdfa244a9b16109c9183af98f,
title = "Common controversies in the management of gallbladder cancer",
abstract = "Gallbladder cancer is a rare and lethal malignancy. Most patients are best served at high-volume centers of excellence, where they are likely to receive evidence-based care derived from a multidisciplinary approach. Surgical resection is recommended for early-stage disease, whereas if the disease is unresectable, the treatment options include biliary drainage, gemcitabine-based combination chemotherapy, fluoropyrimidine chemoradiation, clinical trial enrollment, or best supportive care. While treatment by T-stage is straightforward in many cases, the debate regarding simple versus radical cholecystectomy is still active for patients with T1b disease. Other controversies exist over the necessity of resecting the bile duct and port sites, the extent of lymph node dissection and hepatic resections, and the value of resection for patients with jaundice.",
author = "Chandrakanth Are",
year = "2014",
month = "5",
day = "1",
doi = "10.6004/jnccn.2014.0201",
language = "English (US)",
volume = "12",
pages = "833--835",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "5 SUPPL.",

}

TY - JOUR

T1 - Common controversies in the management of gallbladder cancer

AU - Are, Chandrakanth

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Gallbladder cancer is a rare and lethal malignancy. Most patients are best served at high-volume centers of excellence, where they are likely to receive evidence-based care derived from a multidisciplinary approach. Surgical resection is recommended for early-stage disease, whereas if the disease is unresectable, the treatment options include biliary drainage, gemcitabine-based combination chemotherapy, fluoropyrimidine chemoradiation, clinical trial enrollment, or best supportive care. While treatment by T-stage is straightforward in many cases, the debate regarding simple versus radical cholecystectomy is still active for patients with T1b disease. Other controversies exist over the necessity of resecting the bile duct and port sites, the extent of lymph node dissection and hepatic resections, and the value of resection for patients with jaundice.

AB - Gallbladder cancer is a rare and lethal malignancy. Most patients are best served at high-volume centers of excellence, where they are likely to receive evidence-based care derived from a multidisciplinary approach. Surgical resection is recommended for early-stage disease, whereas if the disease is unresectable, the treatment options include biliary drainage, gemcitabine-based combination chemotherapy, fluoropyrimidine chemoradiation, clinical trial enrollment, or best supportive care. While treatment by T-stage is straightforward in many cases, the debate regarding simple versus radical cholecystectomy is still active for patients with T1b disease. Other controversies exist over the necessity of resecting the bile duct and port sites, the extent of lymph node dissection and hepatic resections, and the value of resection for patients with jaundice.

UR - http://www.scopus.com/inward/record.url?scp=84902489987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902489987&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2014.0201

DO - 10.6004/jnccn.2014.0201

M3 - Article

C2 - 24853228

AN - SCOPUS:84902489987

VL - 12

SP - 833

EP - 835

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 5 SUPPL.

ER -